What is Karl Kellawan's NPI number?

Karl Kellawan's National Provider Identifier (NPI) is 1356359517, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Karl Kellawan's specialty?

Karl Kellawan is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Karl Kellawan located?

Karl Kellawan's practice location on file with NPPES is 220 E Spring Valley Pike, Centerville, OH 45458-2653.

What is Karl Kellawan's phone number?

The practice phone number listed in the NPPES registry for Karl Kellawan is (937) 438-3376.

Does Karl Kellawan accept Medicare?

Karl Kellawan is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Karl Kellawan's NPI active?

Yes — Karl Kellawan's NPI (1356359517) is active in the NPPES registry as of the last update on 2023-07-26.

IndividualActiveAccepts Medicare

Karl Kellawan, M.D.

NPI 1356359517 · Dermatology Physician · Centerville, OH

Karl Kellawan, M.D. is a Dermatology Physician provider in Centerville, OH (NPI 1356359517).

Provider details

NPI number: 1356359517
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Male
Sole proprietor: No
License: 35056902 (OH)

Practice location

220 E Spring Valley Pike

Centerville, OH 45458-2653

Phone: (937) 438-3376

Fax: (937) 438-9424

Street-level locationGet directions

More OH providers

Mailing address

801 York St

Manitowoc, WI 54220-4630

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 35056902 (OH)
Allopathic & Osteopathic Physicians

Additional practice locations (1)

1149 Stone Dr Ste 100
Harrison, OH 45030-1676
Phone: (513) 845-8120
Fax: (513) 845-8121

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(93/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
2 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
6,253 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	2,189	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,722	$88
Destruction of Precancer Skin Growth, 1 Growth17000	776	$56
Biopsy of Related Skin Growth, First Growth11102	331	$91
Destruction of Skin Growth, 1-14 Growths17110	299	$106
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 25 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Clobetasol Propionate	464	327
Ketoconazole	376	195
Triamcinolone Acetonide	223	183
Doxycycline Hyclate	76	27
Metronidazole	51	33
Prednisone	47	33
Finasteride	43	13
Valacyclovir Hclbrand: Valacyclovir

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$4,213 across 273 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-08-04
Last updated: 2023-07-26
Certified: 2023-07-26

Frequently asked questions

What is Karl Kellawan's NPI number?: Karl Kellawan's National Provider Identifier (NPI) is 1356359517, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Karl Kellawan's specialty?: Karl Kellawan is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Karl Kellawan located?: Karl Kellawan's practice location on file with NPPES is 220 E Spring Valley Pike, Centerville, OH 45458-2653.
What is Karl Kellawan's phone number?: The practice phone number listed in the NPPES registry for Karl Kellawan is (937) 438-3376.
Does Karl Kellawan accept Medicare?: Karl Kellawan is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Karl Kellawan's NPI active?: Yes — Karl Kellawan's NPI (1356359517) is active in the NPPES registry as of the last update on 2023-07-26.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	2,189	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,722	$88
Destruction of Precancer Skin Growth, 1 Growth17000	776	$56
Biopsy of Related Skin Growth, First Growth11102	331	$91
Destruction of Skin Growth, 1-14 Growths17110	299	$106
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More

Drug

Part D claims (2024)

Beneficiaries

Clobetasol Propionate

464

327

Ketoconazole

376

195

Triamcinolone Acetonide

223

183

Doxycycline Hyclate

Metronidazole

Prednisone

Finasteride

Valacyclovir Hclbrand: Valacyclovir

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$4,213 across 273 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (1)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (1)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments